Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Status:
Completed
Trial end date:
2002-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Bone marrow and peripheral stem cell transplantation may be able to replace immune
cells that were destroyed by chemotherapy or radiation therapy used to kill tumor cells.
PURPOSE: Phase I trial to study the effectiveness of bone marrow and peripheral stem cell
transplantation in treating patients who have hematologic cancer.